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Basem Azab1*, Masood A Shariff2, Rana Bachir2, John P Nabagiez2 and Joseph T McGinn Jr1,2Abstract
Background: Neutrophil lymphocyte ratio (NLR) is a predictor of major adverse cardiovascular outcomes. Our study
explores the value of NLR in predicting long-term mortality after minimally invasive coronary artery bypass surgery
(MICS) via lateral left-thoracotomy versus conventional sternotomy coronary artery bypass grafting (CABG) surgery.
Methods: A total of 1126 consecutive patients (729 sternotomy CABG and 397 MICS) from a single tertiary center
between 2005 and 2008 were followed until 2011. We stratified the patients into equal tertiles according to
preoperative NLR. The primary outcome, all-cause mortality, was compared among the NLR tertiles.
Results: Out of the 1126 patients included in the study, 1030 (91%) patients underwent off-pump CABG . The first
(NLR <2.3) tertile had a significantly lower 5-year mortality (30/371 =8%) in comparison to the second (NLR =2.3-3.4)
and third (NLR ≥3.5) tertiles (49/375 =13% and 75/380 =20%), respectively with p < 0.0001. After multivariate
adjustment, NLR was a significant independent predictor of mortality (hazard ratio [HR] per each unit increase of
NLR was 1.05, 95% confidence interval [CI] 1.01-1.10, p = 0.008). MICS and sternotomy CABG groups with NLR <3
had similar mortality (21/221 =9.5% and 40/403 =9.9%), p = 1. However among patients with NLR ≥3, MICS had a
significantly lower mortality (23/176 = 13.1%) compared to the sternotomy CABG (70/326 =21.5%), p = 0.02.
According to the multivariate analysis of patients with NLR ≥3, MICS had a significantly lower mortality compared
to sternotomy CABG (HR = 0.44, 95% CI 0.24-0.78, p = 0.005).
Conclusion: Elevated preoperative NLR is an independent predictor of long-term mortality after CABG. Among the
patients with NLR ≥ 3, MICS was associated with a significantly improved survival compared with sternotomy CABG.
Keywords: Inflammatory cells, Minimally invasive surgery, CABG, Thoracotomy, OutcomesBackground
Neutrophil lymphocyte ratio (NLR), a simple inflammatory
marker, was found to be a significant independent predictor
of adverse outcomes in patients with coronary artery dis-
ease [1-3]. The preoperative NLR was also a significant pre-
dictor of mortality among patients who underwent
coronary artery bypass grafting surgery (CABG) [4]. Our
goal was to evaluate the preoperative NLR as a predictor of
mortality using our CABG population which includes both* Correspondence: basemnady2000@yahoo.com
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reproduction in any medium, provided the ora conventional sternotomy CABG and the minimally inva-
sive coronary artery bypass grafting (MICS) approach via
left-thoracotomy [5]. We hypothesize that patients with ele-
vated NLR, reflecting a higher preoperative inflammatory
burden, will have better survival with MICS in comparison
to sternotomy CABG. We evaluated the impact of these
two different surgical approaches in patients with elevated
NLR.Methods
This is an observational study of a prospectively maintained
database to explore the predictive value of NLR on long-
term survival of 1,177 patients who underwent coronaryd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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versity Hospital in Staten Island, New York, a population of
443,728, between January 2005 and December 2008. A total
of 1126 patients were included in the study and followed
through December 2010; mean follow-up was 49 ±
15.2 months, with a range of 21 to 70 months. The only in-
clusion criterion was a preoperative complete blood count.
Exclusion criteria included: hematological proliferative dis-
eases, active or chronic inflammatory or autoimmune dis-
eases, steroid therapy, concomitant valve surgery or
unavailable complete blood count with differential pre-
operatively. Fifty-one patients were excluded from the
study: 22 patients with concomitant valve surgery, 6 pa-
tients with hematological disease, 14 on steroids and 9 who
did not have complete blood count with differential pre-
operatively. The primary end point, all cause five year mor-
tality, was obtained from the electronic medical record and
the social security death index. Differential leukocyte
counts were obtained by the Coulter counter technique
(Coulter Gen S Hematology Analyzer, Beckman Coulter
Corp ®, Hialeah, Florida).
Trained physicians reviewed electronic medical records
for potential confounders, including demographic variables,
coronary artery disease risk factors, comorbidities, pre-
scribed medications before surgery and medications at
discharge, operative variables, laboratory values, left ven-
tricular ejection fraction, New York Heart Association
(NYHA) and Canadian Cardiovascular Society (CCS) class
(Tables 1 and 2). We obtained left ventricular ejection frac-
tion from echocardiography reports. Positive smoking sta-
tus included both current and prior smokers. To study the
baseline characteristics according to the NLR, the patients
were divided into equal tertiles according to NLR: 1st tertile
(NLR <2.2 with 371 patients), 2nd tertile (2.2 ≤NLR ≤ 3.4
with 375 patients), and 3rd tertile (NLR >3.4 with 380 pa-
tients). The study was powered to evaluate the primary out-
come with an estimated 7% 5-year mortality (7% versus
14%) difference between patients in the 1st and 3rd NLR
tertiles. To achieve this difference with an 80% power and a
5% type 1 error required a minimum of 305 patients in
each NLR tertile.
The NLR tertiles were analyzed using the chi-square
test for categorical variables and Kruskall-Wallis test for
continuous variables. The distributions of continuous
and categorical variables were represented as mean ±
standard deviation, frequencies and percentages, respect-
ively. A univariate screen of all potential predictors of
mortality using a separate Cox proportional hazards
model for each variable was performed. Those variables
that were found to be statistically significant (p < 0.05) as
well as clinically meaningful in the univariate analyses
were included in a multivariate Cox regression model.
Backwards selection with significance level for removal
from the model set at 0.1 was used to remove variableswhich did not significantly contribute information to this
model, given other factors included in the model.
In order to avoid collinearity preoperative neutrophils
and lymphocytes were not included in the model with
preoperative NLR. The analysis of mortality was accom-
plished by applying standard methods of survival ana-
lysis (i.e., computing the Kaplan-Meier product limit
curves where the data was stratified by NLR tertiles). In
cases where the endpoint event (death) had not yet oc-
curred the number of months until last follow-up was
used and considered censored. The three NLR groups
were compared using the log-rank test. Additionally,
among elevated NLR group, a multivariate logistic re-
gression was performed to find the best model that fits
the data and that explains the association between mor-
tality and several independent variables deemed either to
have significant association with mortality as a binary re-
sponse or to be considered as clinically important. A
backward selection procedure, with significance level for
removal from the model set at 0.1 was used. The odds
ratios (OR) and 95% confidence interval (CI) of the best
fitted model were computed. Two models were
conducted in this multivariate stage. All analyses were
performed using SPSS version 19.0 (SPSS Inc., Chicago,
IL, USA). This study was approved by the institutional
review board at Staten Island University Hospital.
Results
Out of the 1126 patients included in the study, 1030
(91%) patients underwent off-pump CABG (MICS, 376/
397 = 95%; Sternotomy CABG, 654/729 = 90%). The pa-
tients in the highest NLR tertile were significantly older
with more Caucasian individuals in comparison to the
lowest NLR tertile (p < 0.0001). Additionally, the patients
in the highest NLR tertile had significantly higher pre-
operative serum creatinine and glucose levels with a
higher prevalence of diabetes, preoperative end stage
renal disease requiring hemodialysis and family history
of coronary artery disease compared to those in the low-
est NLR tertile. The three NLR tertiles had similar distri-
bution of both preoperative NYHA and CCS classes.
Postoperatively, the patients in the highest NLR tertiles
suffered a significantly higher rate of renal failure requir-
ing hemodialysis and new onset atrial fibrillation in com-
parison to those in the lowest NLR tertile.
The patients in the lowest NLR tertile had significantly
lower 30-day, 6-month, 1-year and 5-year mortality rates
(0.5%, 1.6%, 2.4% and 8%) in comparison to the middle
NLR tertile (1.3%, 4.3%, 5.1% and 13%) and the highest
NLR tertile (2.7%, 7.7%, 9.9% and 20%), respectively with
p < 0.0001. When we compared the overall survival among
MICS and sternotomy subgroups in each NLR tertile, the
MICS had significantly lower mortality only among the
highest NLR tertile (p value <0.001 according to two tailed
Table 1 Baseline characteristics (demographic and presentation) of coronary artery bypass patients according to neutrophil lymphocyte ratios (NLR) and
surgical approach (MICS vs. Sternotomy CABG)
Variables NLR <2.3 (N = 371) p Value 2.3 ≤NLR ≤ 3.4 (N = 375) p Value NLR >3.4 (N = 380) p Value
Sternotomy CABG MICS Sternotomy CABG MICS Sternotomy CABG MICS
n 242 129 245 130 243 137
Age (years) 62.5 ± 10.2 60.7 ± 10.9 0.12 64.3 ± 11.0 62.6 ± 10.7 0.14 67.5 ± 11.0 65.6 ± 10.7 0.10
Male 174 (71.9%) 90 (69.8%) 0.67 172 (70.5%) 93 (71.0%) 0.92 178 (73.3%) 100 (73.0%) 0.96
Race (Caucasian) 200 (82.6%) 106 (82.2%) 0.09 218 (89.3%) 123 (93.9%) 0.14 227 (93.4%) 128 (93.4%) 1.00
Body Mass Index (kg/m2) 29.1 ± 5.09 29.4 ± 5.42 0.65 30.0 ± 5.70 29.9 ± 6.22 0.95 28.8 ± 5.50 28.7 ± 5.71 0.81
Death 21 (8.7%) 9 (7.0%) 0.57 32 (13.1%) 17 (13.0%) 0.97 57 (23.5%) 18 (13.1%) 0.02
Family history of CAD 101 (41.7%) 63 (48.8%) 0.19 79 (32.4%) 45 (34.4%) 0.7 89 (36.6%) 41 (29.9%) 0.19
Smoking 149 (62.9%) 65 (50.4%) 0.02 141 (59.7%) 72 (55.4%) 0.42 134 (55.6%) 69 (50.4%) 0.33
Hypertension 172 (71.1%) 98 (76.6%) 0.26 180 (74.1%) 93 (71.0%) 0.52 181 (74.5%) 113 (83.1%) 0.05
Diabetes mellitus 94 (38.8%) 33 (25.6%) 0.01 73 (29.9%) 33 (25.2%) 0.33 96 (39.5%) 47 (34.3%) 0.32
Peripheral arterial disease 29 (12.0%) 13 (10.1%) 0.58 36 (14.8%) 7 (5.3%) 0.006 39 (16.0%) 14 (10.2%) 0.12
Renal failure on dialysis 3 (1.2%) 1 (0.8%) 0.68 3 (1.2%) 5 (3.8%) 0.1 8 (3.3%) 9 (6.6%) 0.14
Myocardial infarction 134 (55.4%) 51 (39.5%) 0.004 132 (54.1%) 52 (39.7%) 0.008 130 (53.5%) 38 (27.7%) <0.001
History of PCI 71 (29.3%) 23 (17.8%) 0.02 66 (27.0%) 31 (23.7%) 0.48 58 (23.9%) 23 (16.8%) 0.11
Prior CABG 7 (2.9%) 2 (1.6%) 0.51 7 (2.9%) 1 (0.8%) 0.27 9 (3.7%) 2 (1.5%) 0.34
Prior heart failure 37 (15.3%) 7 (5.4%) 0.005 41 (16.8%) 9 (6.9%) 0.007 45 (18.5%) 11 (8.0%) 0.01
Prior cerebrovascular event 31 (12.8%) 8 (6.2%) 0.048 39 (16.0%) 11 (8.4%) 0.04 50 (20.6%) 12 (8.8%) 0.003
C0PD 30 (12.4%) 10 (7.9%) 0.18 34 (13.9%) 16 (12.2%) 0.64 34 (14.0%) 16 (11.7%) 0.52
Preoperative CCS
none 0 (0%) 1 (0.8%) 0.14 2 (0.8%) 0 (0%) 0.02 2 (0.8%) 0 (0%) <0.001
Class I 42 (17.6%) 24 (18.6%) 34 (13.9%) 32 (24.4%) 41 (17.2%) 28 (20.6%)
Class II 61 (25.5%) 45 (34.9%) 74 (30.3%) 47 (35.9%) 46 (19.3%) 49 (36.0%)
Class III 68 (28.5%) 33 (25.6%) 75 (30.7%) 29 (22.1%) 83 (34.9%) 45 (33.1%)
Class IV 68 (28.5%) 26 (20.2%) 59 (24.2%) 23 (17.6%) 66 (27.7%) 14 (10.3%)
NYHA
Class I 22 (17.9%) 21 (19.4%) 0.21 25 (29.2%) 25 (24.0%) 0.31 30 (23.8%) 22 (21.2%) 0.03
Class II 33 (26.8%) 40 (37.0%) 42 (32.3%) 39 (37.5%) 26 (20.6%) 33 (31.7%)
Class III 44 (35.8%) 26 (24.1%) 37 (28.5%) 19 (18.3%) 38 (30.2%) 37 (35.6%)
Class IV 24 (19.5%) 21 (19.4%) 26 (20.0%) 21 (20.2%) 32 (25.4%) 12 (11.5%)
















Table 1 Baseline characteristics (demographic and presentation) of coronary artery bypass patients according to neutrophil lymphocyte ratios (NLR) and
surgical approach (MICS vs. Sternotomy CABG) (Continued)
Preoperative laboratory values
Leukocyte (k/cc) 7.42 ± 2.31 7.20 ± 2.03 0.37 8.09 ± 2.22 7.61 ± 2.20 0.05 9.70 ± 3.13 8.87 ± 2.71 0.01
Neutrophils (k/cc) 4.06 ± 1.35 3.94 ± 1.29 0.40 5.28 ± 1.55 4.97 ± 1.51 0.06 7.45 ± 2.82 6.76 ± 2.45 0.01
Lymphocytes (k/cc) 2.45 ± 1.10 2.40 ± 0.763 0.40 1.91 ± 0.566 1.79 ± 0.533 0.06 1.35 ± 0.462 1.29 ± 0.455 0.24
Monocytes (k/cc) 0.62 ± 0.286 0.62 ± 0.241 0.80 0.65 ± 0.263 0.60 ± 0.225 0.12 0.69 ± 0.299 0.62 ± 0.237 0.02
Creatinine (mg/dl) 1.06 ± 0.741 1.07 ± 0.983 0.99 1.14 ± 0.711 1.19 ± 1.02 0.56 1.26 ± 0.61 1.18 ± 0.604 0.06
Glucose (mg/dl) 124.0 ± 48.9 122.4 ± 52.4 0.76 126.1 ± 49.3 110.8 ± 41.6 0.002 136.2 ± 58.8 121.5 ± 46.3 0.01
CABG coronary artery bypass grafting, CAD coronary artery disease, CCS Canadian Cardiovascular Society Angina classification system, COPD chronic obstructive pulmonary disease, NYHA New York Heart Association
















Table 2 Operative and post-operative characteristics (management and laboratory) of coronary artery bypass patients according to neutrophil lymphocyte
ratios (NLR) and surgical approach (MICS vs. Sternotomy CABG)
Variables NLR <2.3 (N = 371) p Value 2.3 ≤NLR ≤ 3.4 (N = 375) p Value NLR >3.4 (N = 380) p Value
Sternotomy CABG MICS Sternotomy CABG MICS Sternotomy CABG MICS
n 242 129 245 130 243 137
In-hospital medication
Aspirin 238 (98.3%) 128 (99.2%) 0.66 234 (95.9%) 130 (100%) 0.02 237 (97.5%) 137 (100%) 0.09
Clopidogrel 110 (45.5%) 111 (86.0%) <0.001 128 (52.5%) 115 (88.5%) <0.001 120 (49.4%) 116 (84.7%) <0.001
Beta-blockers 232 (95.9%) 124 (96.1%) 0.91 230 (94.3%) 128 (98.5%) 0.06 231 (95.1%) 135 (98.5%) 0.08
Angiotensin convertase inhibitor 84 (34.7%) 44 (34.1%) 0.91 96 (39.3%) 31 (23.8%) 0.00 104 (42.8%) 45 (32.8%) 0.06
Angiotensin receptor blocker 29 (12.0%) 13 (10.1%) 0.58 17 (7.0%) 13 (10.0%) 0.30 19 (7.8%) 17 (12.4%) 0.14
Warfarin 18 (7.4%) 7 (5.4%) 0.46 18 (7.4%) 8 (6.2%) 0.66 26 (10.7%) 9 (6.6%) 0.18
Statin 232 (95.9%) 127 (98.4%) 0.23 229 (93.9%) 126 (96.9%) 0.20 228 (93.8%) 132 (96.4%) 0.29
Medication on discharge
Aspirin 237 (98.3%) 125 (97.7%) 0.70 234 (95.9%) 127 (97.7%) 0.56 230 (95.4%) 131 (97.8%) 0.26
Clopidogrel 66 (27.4%) 101 (78.9%) <0.001 83 (34.0%) 105 (80.8%) <0.001 64 (26.6%) 104 (77.6%) <0.001
Beta-blockers 212 (88.0%) 114 (89.1%) 0.76 216 (88.5%) 117 (90.0%) 0.66 208 (86.3%) 123 (91.8%) 0.11
Angiotensin convertase inhibitor 70 (29.0%) 32 (25.0%) 0.41 67 (27.5%) 24 (18.5%) 0.05 75 (31.1%) 27 (20.1%) 0.02
Angiotensin receptor blocker 1 (0.4%) 4 (3.1%) 0.05 4 (1.7%) 1 (0.8%) 0.66 2 (0.8%) 7 (5.2%) 0.01
Warfarin 30 (12.4%) 17 (13.3%) 0.82 27 (11.1%) 12 (9.2%) 0.58 43 (17.8%) 11 (8.2%) 0.01
Statin 220 (91.3%) 119 (93.0%) 0.57 222 (91.0%) 120 (92.3%) 0.66 218 (90.5%) 123 (91.8%) 0.67
Operative data
Internal mammary artery utilized 231 (95.5%) 127 (98.4%) 0.23 230 (94.3%) 128 (97.7%) 0.13 221 (90.9%) 134 (97.8%) 0.01
Number of conduits used for bypass 3.28 ± 0.991 2.12 ± 0.673 <0.001 3.26 ± 0.886 2.28 ± 0.806 <0.001 3.12 ± 0.910 2.17 ± 0.753 <0.001
Cardiopulmonary bypass 27 (11.2%) 6 (4.7%) 0.04 30 (12.3%) 7 (5.3%) 0.03 18 (7.4%) 8 (5.8%) 0.56
Postoperative complications
Renal Failure on Dialysis 1 (0.4%) 2 (1.6%) 0.28 3 (1.2%) 4 (3.1%) 0.25 12 (4.9%) 3 (2.2%) 0.19
New onset atrial fibrillation 33 (13.6%) 22 (17.1%) 0.38 40 (16.4%) 30 (22.9%) 0.12 48 (19.8%) 43 (31.4%) 0.01
Septicemia 0 (0%) 5 (3.9%) 0.005 0 (0%) 2 (1.5%) 0.12 6 (2.5%) 2 (1.5%) 0.72
















Figure 1 The 5-year all-cause mortality after coronary bypass surgery according to preoperative neutrophil lymphocyte ratio (NLR)
and surgical approach(MICS vs. Sternotomy CABG). According to Fisher’s exact test the 5-year mortality rates were higher in the sternotomy
CABG patients with NLR >3.4 compared to MICS with NLR >3.4 (p value <0.0001 ). MICS =minimal invasive cardiac surgery; CABG = coronary
artery bypass grafting. The average follow-up was 49 ± 15.2 months (range 21–70 months). Total of 467 patients had 5-year follow up period.
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curves showed significant difference (Log rank [Mantel-
Cox] p < 0.0001) mortality in the highest NLR tertile (NLR
>3.4) compared to the middle (NLR 2.3-3.4) and the lowest
(NLR <2.3) NLR tertiles (Figure 2). Table 3 demonstrates
the univariate screening analysis (the individual Cox regres-
sions examining the association between each variable andFigure 2 Kaplan-Meier Curve of mortality among patients undergoing
lymphocyte ratio (NLR) tertiles. Log rank (Mantel-Cox) p < 0.0001. The av
467 patients had 5-year follow up period.overall survival). In our study population, the variables
associated with increased mortality were age, chronic pul-
monary disease, congestive heart failure, prior cerebrovas-
cular event, diabetes, family history of coronary artery
disease, pre- and post-operative renal failure requiring dia-
lysis, intraoperative use of cardiopulmonary bypass (CPB),
elevated preoperative neutrophil, NLR, serum creatinine,coronary artery bypass surgery according to their neutrophil
erage follow-up was 49 ± 15.2 months (range 21–70 months). Total of
Table 3 Hazard ratios of baseline characteristics for all-
cause mortality among coronary artery bypass surgery
patients (univariate analysis)
Variable Hazard ratio (95%
confidence interval)
p Value
Male 0.63 (0.45–0.87) 0.005
Age (per year) 1.06 (1.06–1.09) <0.001
Race (Caucasian) 1.40 (0.78-2.53) 0.26
Body Mass Index
(kg/m2) (31+)
18–25 1.35 (0.90–2.03) 0.14
26–30 1.11 (0.75–1.64) 0.60
Ejection fraction (%) 1.01 (0.99–1.02) 0.46
Hypertension 1.31 (0.89–1.93) 0.17
Smoking 0.89 (0.65–1.23) 0.48
Chronic pulmonary disease 2.02 (1.37–2.96) <0.001
Prior myocardial infarction 1.00 (0.73–1.37) 0.99
Prior coronary angioplasty 1.16 (0.81–1.65) 0.41
Prior coronary artery bypass
graft
0.67 (0.21–2.09) 0.48
Congestive heart failure 1.64 (1.11–2.43) 0.01
Prior cerebrovascular event 1.79 (1.22–2.62) 0.003
Family history of coronary
artery disease
0.56 (0.39–0.80) 0.001
Renal Failure on Dialysis 3.95 (2.19–7.12) <0.001
Diabetes Mellitus 1.60 (1.17–2.21) 0.004
Peripheral arterial disease 1.39 (0.91–2.14) 0.12
Pre-Operative CCS 1.01 (0.87–1.18) 0.85
Pre-Operative NYHA 0.86 (0.71–1.06) 0.15
Pre-Operative Leukocyte 1.05 (0.99–1.11) 0.11
Pre-Operative Neutrophils 1.08 (1.02–1.15) 0.01
Pre-Operative Lymphocytes 0.69 (0.55–0.88) 0.003
Pre-Operative Monocytes 1.46 (0.91–2.36) 0.11
Pre-Operative Creatinine 1.20 (1.09–1.31) <0.001
Pre-Operative Glucose 1.00 (1.00–1.01) <0.001






Number of conduits used
for bypass
0.96 (0.82–1.13) 0.64
Renal failure on dialysis 6.80 (3.91–11.80) <0.001
Cardiopulmonary bypass 1.76 (1.11–2.79) 0.01
New onset atrial fibrillation 2.03 (1.41–2.91) <0.001
Septicemia 6.95 (3.54–13.65) <0.001
CCS Canadian Cardiovascular Society Angina classification system,
NLR neutrophil lymphocyte ratio, NYHA New York Heart Association
Functional Classification.
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atrial fibrillation (Table 3). Male gender, use of internal
mammary artery and higher lymphocyte count were associ-
ated with lower mortality. Elevated WBC, neutrophil, NLR
and lower lymphocyte count were significant predictors of
mortality in the univariate screening models. In the multi-
variate Cox proportional hazard models, including the
confounding variables, NLR was the only independent pre-
dictor of long-term mortality (HR per unit increase in NLR
was 1.06, CI 95% was 1.014-1.099, p = 0.008) (Table 4).
When patients were divided into two groups according
to the median NLR (NLR = 3) of the whole population, we
found 624 patients with NLR <3 and 502 with NLR ≥3.
Among the patients with NLR <3, there was no significant
difference in the overall survival between the MICS and
sternotomy CABG (21/221 = 9.5% vs. 40/403 = 9.9%, p = 1).
Contrarily, the patients with NLR ≥ 3 who underwent
MICS had a significantly lower mortality compared to
sternotomy CABG (23/176 = 13.1% vs. 70/326 = 21.5%,
p = 0.022). Kaplan-Meier curves showed significant differ-
ence in (Log rank [Mantel-Cox] p < 0.002) mortality be-
tween the MICS and sternotomy CABG with NLR ≥ 3
compared to NLR <3, p = 0.002 (Figure 3). Additionally, the
patients with NLR ≥ 3 who underwent MICS had a signifi-
cantly lower mortality (20/166 = 12% vs. 63/293 = 21.5%,
p =0.011) compared to those who underwent off-pump
sternotomy CABG, after excluding MICS patients who
underwent CPB. Among the patients with NLR ≥ 3, multi-
variate regression models demonstrated that MICS CABG
decreased the odd ratios of all-cause mortality by 56% and
50% according to model A and B, respectively (Table 5),
compared to sternotomy.Table 4 NLR multivariate adjusted all-cause mortality Cox
proportional hazard ratio in coronary bypass surgery
patients
Variables HR 95% CI p Value
Pre-Operative NLR (per unit) 1.06 1.01–1.10 0.008
Age (per year) 1.07 1.05–1.09 <0.001
Male gender 0.73 0.51–1.03 0.06
Family history of coronary artery disease 0.71 0.49–1.04 0.07
Smoking 1.37 0.96–1.95 0.08
Preoperative renal failure on dialysis 5.56 2.98–10.4 <0.001
Chronic pulmonary disease 1.73 1.15–2.59 0.008
In-hospital angiotensin convertase inhibitor 1.41 1.00–1.99 0.05
In-hospital statin 0.37 0.20–0.67 0.001
Aspirin on discharge 0.29 0.15–0.56 <0.001
Postoperative renal failure on dialysis 2.34 1.16–4.71 0.01
Postoperative septicemia 2.99 1.29–6.93 0.01
Preoperative Glucose (pre mg/dl) 1.01 1.00–1.01 <0.001
NLR neutrophil lymphocyte ratio, HR hazard ratio, CI confidence interval.
Figure 3 Kaplan-Meier Curve of mortality among patients undergoing coronary bypass surgery according to their neutrophil
lymphocyte ratio (NLR) cutoffs: NLR <3 and NLR ≥3 (p = 0.002). The average follow-up was 49 ± 15.2 months (range 21–70 months). Total of
467 patients had 5-year follow up period.
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The principle finding of our study is that elevated pre-
operative NLR independently predicts long term mortal-
ity in patients undergoing coronary artery bypass
surgery via minimally invasive and sternotomy ap-
proaches. Those with elevated preoperative NLR ≥3 had
better survival with MICS than with sternotomy CABG
after adjusting for confounding variables. Elevated NLR
was associated with a higher prevalence of diabetes,
renal failure, and elevated serum creatinine and glucose.
This association concurs with existing literature that de-
scribes these conditions as proinflammatory [6,7].Similar to a prior study, we have observed an association
between elevated preoperative NLR and the develop-
ment of postoperative new onset atrial fibrillation [4].
Similar to prior studies, we found that NLR is superior
to WBC, neutrophil and lymphocyte counts in
predicting mortality. Because it is a ratio, NLR is rela-
tively more stable than individual leukocytic parameters
that are easily altered by many simple conditions (e.g.
dehydration, over-hydration, diluted blood specimens,
in-vitro blood specimen handling). In the NLR, the nu-
merator is the neutrophil count (a higher neutrophil
count is associated with an increased risk of death) and
Table 5 Multivariate logistic regression models for all-
cause mortality among patients with preoperative































Model A included history of prior coronary angioplasty, MICS vs. sternotomy
CABG, postoperative new onset atrial fibrillation, use of internal mammary
artery, use of cardiopulmonary bypass, clopidogrel on discharge and in-
hospital, coumadin on discharge, beta blockers on discharge.
Model B included age, gender, family history of coronary artery disease,
history of renal dialysis, statin on discharge, coumadin on discharge, use of
internal mammary artery, MICS vs. sternotomy CABG and postoperative new
onset atrial fibrillation.
MICS minimal invasive cardiac surgery (thoracotomy), CABG coronary artery
bypass graft.
Azab et al. Journal of Cardiothoracic Surgery 2013, 8:193 Page 9 of 11
http://www.cardiothoracicsurgery.org/content/8/1/193the denominator is the lymphocyte (a lower lymphocyte
count is associated with an increased risk of death). This
makes the NLR an augmented predictor of mortality.
We hypothesize that an elevated neutrophil count is a
marker for an active inflammatory process and a low
lymphocyte count is a marker of failure to control this
active inflammatory process. Many studies have demon-
strated that neutrophils play a major role in atheroscler-
osis and plaque instability through various mediators
such as neutrophil gelatinase-associated lipocalin
(NGAL), neutrophil-elastase, myeloperoxidase, defensins
and cathelicidin [8-11]. Studies have also demonstrated
that preoperative statin therapy increases neutrophil
apoptosis and reduces neutrophil-endothelial adhesion
after cardiac surgery. These desirable statin effects were
irrespective of lipid lowering action [12,13].
We hypothesize that a reduced peripheral blood lympho-
cyte count acts as a marker for an ongoing nonspecific ath-
erosclerotic inflammatory process. Lymphopenia has been
shown to be associated with atherosclerosis progression
and major adverse cardiac outcomes [14,15]. Lymphocytes
modulate smooth muscle proliferation via interferongamma [16] which controls the course of luminal
narrowing in atherosclerosis.
Prior studies evaluated CPB as a confounding variable
to the inflammatory response after MICS versus
sternotomy CABG. Gu et al. demonstrated in a random-
ized controlled trial (31 patients in each arm) that an-
terolateral thorocotomy was associated with a lower
inflammatory response (leukocyte elastase, platelet β-
thromboglobulin, and complement C) than sternotomy
CABG [17]. However some of the sternotomy CABG pa-
tients in this study underwent CPB, which is believed by
many to contribute greatly to the postoperative inflam-
matory response. According to our multivariate analysis,
NLR predicted mortality after adjusting for CPB. Simi-
larly in patients with NLR >3, MICS had better survival
than sternotomy CABG after adjusting for CPB. More-
over, among patients with NLR >3, MICS off-pump had
a significant lower mortality compared to off-pump
sternotomy CABG. These results demonstrate that CPB
was not a confounding variable to the superiority of
MICS in these patients with elevated inflammatory
marker. However, our study included only 96 on-pump
CABG patients, which requires further studies with lar-
ger number of on-pump patients.
We compared the inflammatory response between
MICS and sternotomy CABG. Gu et al. prospectively
studied the inflammatory response in patients that
underwent CABG without CPB. They found the inflam-
matory response in patients without CPB was lower in
the anterolateral thoracotomy group compared to the
sternotomy group [18]. In a randomized controlled trial
of 30 patients, Diegeler et al. studied various inflamma-
tory markers in three groups of CABG: sternotomy
CABG with CPB, off-pump sternotomy CABG and
limited anterior thoracotomy CABG approaches. The
anterior thoracotomy approach had a lower interleukin
8 (pro-inflammatory marker) and a higher interleukin
10 (anti-inflammatory marker) than the off-pump
sternotomy CABG [19]. The complement 3d, TNF re-
ceptor p55 and p75 showed a significant increase in both
on and off-pump sternotomy CABG, but no change
from the anterior thoracotomy group [19]. In a study of
patients that underwent lung volume reduction surgery,
bilateral thoracoscopic surgery had reduced inflamma-
tory cytokines compared to sternotomy [20]. Likewise, in
an experimental study using animals that underwent
CPB with different surgical approaches, avoidance of
full-sternotomy was associated with a reduced level of
cytokines and inflammatory response. The animals with-
out sternotomy had the lowest pro-inflammatory (IL-6
and IL-8) cytokines compared to mini and full
sternotomy [21].
The superiority of MICS to sternotomy CABG in the
group with high NLR may be related to thymus
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http://www.cardiothoracicsurgery.org/content/8/1/193dysfunction after sternotomy. In a case–control pediatric
study, 29% of children with sternotomy after cardiac sur-
gery had an identifiable thymus on 14-month magnetic
resonance image compared to 92% in the control group
who had no cardiac surgery. The authors suggested that
postoperative residual thymic tissue does not regenerate
[22]. Additionally, in a study that included pediatric and
adult populations, cardiothoracic surgery and incidental
thymectomy were associated with immune dysregulation
and unclear factors that altered the regulatory T cells
[23]. In adult patients, thymectomies were followed by
immune dysregulation and development of autoimmune
diseases [24,25].Limitations
This is a single center study with patients who were
retrospectively enrolled from our database. We have not
included the operating surgeon in our data, which could
be a possible confounding variable. The MICS patients
with high NLR had a higher rate of internal mammary
artery use compared to the sternotomy group with high
NLR. Although the internal mammary artery use was in-
cluded in the multivariate analysis, randomized pro-
spective studies are needed to alleviate such significant
difference in operative variables. We used all-cause mor-
tality rather than cardiac related mortality. We also did
not obtain data regarding other major cardiovascular ad-
verse events during the follow-up period (e.g. myocardial
infarction, stroke and later need for revascularization).
There is the possibility of missing a number of primary
outcomes by using the social security death index and
medical records to assess the survival status. The smok-
ing data are missing exact duration of smoking or cessa-
tion. Another limitation to our study is the lack of
measurement for known inflammatory markers such as
interleukins, C-reactive protein and erythrocyte sedi-
mentation rate. Moreover, we had mostly off-pump
CABG patients (91%), which limits the generalizability
of our findings.Conclusion
Elevated preoperative NLR is an independent predictor
of long-term mortality after CABG. Patients with pre-
operative NLR ≥ 3 had a better 5-year overall survival in
MICS versus sternotomy CABG. This effect was not at-
tributed to cardiopulmonary bypass or any other
confounding variables. Further studies are needed to ex-
plain the mechanism and evaluate therapeutic applica-
tions to these findings.Abbreviations
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